Prime Access named Hispanic AOR for Novo Nordisk’s Diabetes Efforts

New York-based Prime Access announced that it has been appointed agency of record for the US Hispanic market for Novo Nordisk. The agency will be tasked with branded and unbranded strategy development and execution as well as digital and traditional media planning and buying. Prime Access will also spearhead strategic development of Novo Nordisk’s diabetes franchise across other US multicultural markets.

“Prime Access shares our commitment to finding viable solutions to the diabetes pandemic for multicultural communities,” said Tatiana Hansell, Associate Director, Patient Centric Marketing for Novo Nordisk. “Together, we can help improve diabetes prevention, care, and control for Hispanic health care consumers by addressing the psychosocial cultural aspects of diabetes. We were impressed by the agency’s depth of knowledge and their analytic approach that was highly unique compared to what we had seen before.”

“Compared to non-Hispanic whites, the risk of diagnosed diabetes is 66% higher among Hispanics/Latinos and 77% higher among non-Hispanic blacks,” said Steven Millerman, CEO of Prime Access. “Given these statistics, and with the Affordable Care Act providing improved access to care over time, we are looking forward to partnering with Novo Nordisk to provide strategic and analytic integration throughout every aspect of their multicultural capability. We are honored that the Novo Nordisk team has entrusted us